Optimal Tracers empowers our customers’ drug development programs by providing radiolabeling services for PET imaging biomarkers.
We operate on a Quality Systems approach that assures reliable delivery of quality supplies by carefully controlling processes and equipment.
Products for human studies are produced in full compliance with applicable USP chapters, FDA regulations and with the obligation of the sponsor’s IND.
We collaborate closely with our clients to develop tailored solutions for optimizing drug development, production processes, analytical control methods, and regulatory filling. We also help our clients develop clinical imaging protocols.
In addition to our clients novel F-18, C-11, Zr-89, Cu-64, Ga-68, Lu-177, Ac-225, and other PET diagnostic and therapeutic compounds, the Optimal Tracers laboratory is fully equipped for reliable production of most generic clinical and preclinical research PET and SPECT tracers.